Skip to main content

Testosterone Cypionate Injection

Last Updated: December 23, 2022
Status: Current

Products Affected - Description
    • Testosterone cypionate intramuscular injection, Cipla USA, 200 mg/mL, 1 mL vial, 1 count, NDC 69097-0802-32
    • Testosterone cypionate intramuscular injection, Cipla USA, 200 mg/mL, 10 mL vial, 1 count, NDC 69097-0802-37 - discontinued
    • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 1 mL vial, 1 count, NDC 00143-9659-01
    • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 10 mL vial, 1 count, NDC 00143-9726-01
    • Testosterone cypionate intramuscular injection, Padagis, 200 mg/mL, 10 mL vial, 1 count, NDC 00574-0820-10
    • Testosterone cypionate intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, 1 count, NDC 00409-6557-01
    • Testosterone cypionate intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00409-6562-01
    • Testosterone cypionate intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00409-6562-20
    • Testosterone cypionate intramuscular injection, Sun Pharma, 100 mg/mL, 10 mL vial, 1 count, NDC 62756-0017-40
    • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 1 mL vial, 1 count, NDC 62756-0015-40
    • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 10 mL vial, 1 count, NDC 62756-0016-40
Reason for the Shortage
    • Cipla did not provide a reason for the shortage. The 200 mg/mL 10 mL vials were discontinued in 2022.
    • Hikma did not provide a reason for the shortage.
    • Padagis has testosterone cypionate available.
    • Pfizer has testosterone cypionate and Depo-Testosterone on shortage due to increased demand and manufacturing delays.
    • Sun Pharma did not provide a reason for the shortage.
Available Products
    • Depo-Testosterone intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, NDC 00009-0347-02
    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00009-0417-01
    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00009-0417-02
    • Testosterone cypionate intramuscular injection, Padagis, 200 mg/mL, 1 mL vial, 1 count, NDC 00574-0820-01

Estimated Resupply Dates

    • Cipla has testosterone cypionate 200 mg/mL 1 mL vials on back order and the company estimates a release date of December 2022.
    • Hikma has testosterone cypionate 200 mg/mL 10 mL vials on allocation. The 200 mg/mL 1 mL vials are on back order and the company estimates a release date of early- to mid-January 2023.
    • Padagis has testosterone cypionate 200 mg/mL 10 mL vials on back order and the company estimates a release date of late-December 2022.
    • Pfizer has testosterone cypionate 100 mg/mL 10 mL vials and 200 mg/mL 10 mL vials on back order and the company estimates a release date of January 2023. The 200 mg/mL 1 mL vials are available in limited supply.
    • Sun Pharma has testosterone cypionate 100 mg/mL 10 mL and 200 mg/mL 1 mL and 10 mL vials on back order and the company cannot estimate a release date.

Updated

Updated December 23, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.